Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 3 Comparison of plasma lipids and apoproteins levels according to alleles in CAD subjects (n. 102)

From: Genetic study of common variants at the Apo E, Apo AI, Apo CIII, Apo B, lipoprotein lipase (LPL) and hepatic lipase (LIPC) genes and coronary artery disease (CAD): variation in LIPC gene associates with clinical outcomes in patients with established CAD

 

Apo E

Apo B Xba1

LIPC T202T

 

-/2 (14)

3/3 (74)

-/4 (14)

X1 (35)

X2 (67)

C carriers (39)

G carriers (65)

Total cholesterol (mg/dl)

156 ± 20

199.29

204 ± 34*

191 ± 34

206 ± 35

199 ± 41

198 ± 33

HDL-cholesterol (mg/dl)

26.8.4 ± 5.2

25.9 ± 7.1

26.76 ± 6.7

29 ± 9.6

26 ± 2.0*

34 ± 10

31.7 ± 10*

LDL-cholesterol (mg/dl)

98 ± 24

134 ± 31

141 ± 11*

138 ± 35

149 ± 36

130 ± 34

133 ± 39

Total triglycerides (mg/dl)

189.7 ± 45

178.3 ± 101

178.3 ± 80

210 ± 57

212 ± 67

170 ± 83

203 ± 81*

APO AI (mg/dl)

108.3 ± 14

105.4 ± 15

106.0 ± 10

107 ± 17

106 ± 15

119 ± 23

117 ± 22

APO AII (mg/dl)

37 ± 5.2

38 ± 6.1

38 ± 9.2

38.7 ± 6.6

38.5 ± 6.3

41 ± 8.2

41 ± 6.1

APO B (mg/dl)

77 ± 16

110 ± 19

117 ± 21*

100 ± 30

112 ± 22¶

104 ± 27

105 ± 23

APO CII (mg/dl)

4.4 ± 1.8

3.8 ± 1.6

3.7 ± 1.4

4.0 ± 1.3

3.9 ± 1.9

4.0 ± 1.6

3.9 ± 1.7

APO CIII (mg/dl)

11.6 ± 2.3

11.3 ± 2.6

12.7 ± 2.4

13.6 ± 2.1

12.3 ± 2.3

12.8 ± 2.8

12.4 ± 2.9

APO E (mg/dl)

11.0 ± 3.2

7.9 ± 1.7

8.7 ± 1.7¶

9.4 ± 2.7

9.0 ± 2.6

9.4 ± 2.6

9.3 ± 3.1

  1. Data are given as means ± SDM. Significant differences are in bold Apo E: -/2 = carriers of allele ε 2; 3/3 = homozygous carriers of allele ε 3; -/4 carriers allele ε4. *p < 0.01, ¶ p < 0.03 Apo B: X1X1 v. X1X2 + X2X2. *p < 0.01 ¶ p < 0.05 LIPC (Hepatic lipase): C allele carriers (wild type) v. G allele carriers (CG + GG) * p < 0.02; † p < 0.01 The statistical analysis of total triglycerides and LP(a) were performed on log-transformed values, but the untransformed values are given in table. After age-standardisation, continuous variables were compared by t-test and ANOVA, and categorical variables by χ2 test
Back to article page

BMC Medical Genetics

ISSN: 1471-2350

Contact us